Disease: COVID-19-associated fungal infections

Prevalence of fungi and their antifungal and disinfectant resistance in hospital environments: insights into combating nosocomial mycoses

This study examined fungal contamination in hospital intensive care units, finding that Aspergillus and other mold species are commonly present in air and ventilation systems. Importantly, many of these fungi have developed resistance to antifungal medications and hospital disinfectants, making them harder to treat and control. The researchers discovered that the same resistant fungi found in hospitals are similar to those infecting patients, suggesting that hospital environments may be spreading these dangerous infections.

Read More »

Healthcare-associated fungal infections and emerging pathogens during the COVID-19 pandemic

During the COVID-19 pandemic, fungal infections became a serious complication in hospitalized patients, especially those receiving steroids and other immune-suppressing treatments. Common fungal pathogens like Candida and Aspergillus caused dangerous coinfections, with infection rates varying significantly by region. Current antifungal medications have significant limitations including toxicity and resistance, highlighting the urgent need for new and safer antifungal treatments.

Read More »
Scroll to Top